West Virginia Code of State Rules › Agency 11 - Medicine › Title 11 - LEGISLATIVE RULE WEST VIRGINIA BOARD OF MEDICINE › Series 11-10 - Practitioner Requirements for Accesing the West Virginia Controlled Substances Monitoring Program Database › Section 11-10-2 - Definitions

Current through Register Vol. XLI, No. 28, July 12, 2024
2.1. As used in
				this rule, the following words and terms have the following meaning:
2.1.a. "Administering" means the direct
				application of a drug to the body of a patient by injection, inhalation,
				ingestion or any other means.
2.1.b. "Benzodiazepine" means a class of
				controlled substance medications that produce sedation, induce sleep, relieve
				anxiety and prevent seizures and which are generally approved to treat anxiety
				disorder, insomnia, seizures, social phobia, and panic disorder.
2.1.c. "Board" means the West Virginia Board
				of Medicine as described at W. Va. Code §
										30-3-5.
2.1.d. "Controlled substance" means a drug
				that is classified by federal or state law in Schedules I, II, III, IV or V, as
				defined in W. Va. Code Chapter 60A, Article 2.
2.1.e. "CSMP" means the West Virginia
				Controlled Substances Monitoring Program repository and database.
2.1.f. "DEA registration identification
				number" means the federal Drug Enforcement Administration registration
				identification number issued to a practitioner.
2.1.g. "Dispensing" means the preparation and
				delivery of a drug to an ultimate user by or pursuant to a lawful order of a
				practitioner, including the prescribing, packaging, labeling, administering or
				compounding necessary to prepare the drug for that delivery.
2.1.h. "Medical records" means records
				including the medical history and physical examination; diagnostic, therapeutic
				and laboratory results; evaluations and consultations; treatment objectives;
				discussion of risks and benefits; informed consent; treatments; medications
				(including date, type, dosage and quantity provided); instructions and
				agreements; and periodic reviews.
2.1.i. "Opioid" means controlled substance
				medications which are natural and semi-synthetic derivatives of the opium
				poppy, as well as similar synthetic compounds that have analgesic or pain
				relieving properties because of their effects in the central nervous system.
				Opioids include, but are not limited to, codeine, morphine, hydromorphone,
				hydrocodone, oxycodone, methadone, and fentanyl.
2.1.j. "Patient" means a person presenting
				himself or herself for treatment who is not considered by the practitioner as
				suffering from a terminal illness.
2.1.k. "Practitioner" means a physician,
				podiatric physician or physician assistant who possesses a valid DEA
				registration identification number and who is licensed by the Board pursuant to
				Articles 3 or 3E of Chapter 30, or holds an interstate telehealth registration
				issued by the Board pursuant to W. Va. Code § 30-1-26.
2.1.l. "Providing" means prescribing,
				dispensing or administering medication.
2.1.m. "Terminal illness" means an incurable
				or irreversible condition as diagnosed by the attending physician or a
				qualified physician for which the administration of life-prolonging
				intervention will serve only to prolong the dying process.